{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:56:59Z","timestamp":1787626619939,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873934"],"award-info":[{"award-number":["81873934"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.burns.2024.01.026","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T19:03:05Z","timestamp":1707246185000},"page":"936-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exogenous PRAS40 reduces KLF4 expression and alleviates hypertrophic scar fibrosis and collagen deposition through inhibiting mTORC1"],"prefix":"10.1016","volume":"50","author":[{"given":"Chao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-6840","authenticated-orcid":false,"given":"Duyin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.burns.2024.01.026_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/wound.2016.0709","article-title":"Mechanical forces in cutaneous wound healing: emerging therapies to minimize scar formation","volume":"7","author":"Barnes","year":"2018","journal-title":"Adv Wound Care (N Rochelle)"},{"issue":"265","key":"10.1016\/j.burns.2024.01.026_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009337","article-title":"Wound repair and regeneration: mechanisms, signaling, and translation","volume":"6","author":"Eming","year":"2014","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.burns.2024.01.026_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071545","article-title":"Macrophage phenotypes regulate scar formation and chronic wound healing","volume":"18","author":"Hesketh","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.burns.2024.01.026_bib4","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18293.1","article-title":"Toward understanding scarless skin wound healing and pathological scarring","volume":"8","author":"Karppinen","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.burns.2024.01.026_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2018.08.009","article-title":"Current and upcoming therapies to modulate skin scarring and fibrosis","volume":"146","author":"Coentro","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl 1","key":"10.1016\/j.burns.2024.01.026_bib6","article-title":"Keloids and hypertrophic scars: pathophysiology, classification, and treatment","volume":"43","author":"Berman","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.burns.2024.01.026_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41038-015-0026-4","article-title":"The molecular basis of hypertrophic scars","volume":"4","author":"Zhu","year":"2016","journal-title":"Burns Trauma"},{"key":"10.1016\/j.burns.2024.01.026_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2741\/1184","article-title":"Wound healing: an overview of acute, fibrotic and delayed healing","volume":"9","author":"Diegelmann","year":"2004","journal-title":"Front Biosci"},{"issue":"5","key":"10.1016\/j.burns.2024.01.026_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.burns.2024.01.026_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/1061186X.2021.1882470","article-title":"Targeting PRAS40: a novel therapeutic strategy for human diseases","volume":"29","author":"Zhou","year":"2021","journal-title":"J Drug Target"},{"issue":"42","key":"10.1016\/j.burns.2024.01.026_bib11","doi-asserted-by":"crossref","first-page":"14262","DOI":"10.1074\/jbc.RA120.014994","article-title":"TGF\u03b2 acts through PDGFR\u03b2 to activate mTORC1 via the Akt\/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression","volume":"295","author":"Maity","year":"2020","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.burns.2024.01.026_bib12","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00081.2017","article-title":"Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion","volume":"313","author":"Bera","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.burns.2024.01.026_bib13","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00666.2016","article-title":"PDGF receptor-\u03b2 uses Akt\/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (\u03b12) expression","volume":"313","author":"Das","year":"2017","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"10.1016\/j.burns.2024.01.026_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/wrr.12759","article-title":"Activation of mTORC1 in fibroblasts accelerates wound healing and induces fibrosis in mice","volume":"28","author":"Hu","year":"2020","journal-title":"Wound Repair Regen"},{"issue":"1","key":"10.1016\/j.burns.2024.01.026_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-018-07858-8","article-title":"The mTORC1\/4E-BP1 axis represents a critical signaling node during fibrogenesis","volume":"10","author":"Woodcock","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.burns.2024.01.026_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gene.2017.02.025","article-title":"Kr\u00fcppel-like factor 4 (KLF4): what we currently know","volume":"611","author":"Ghaleb","year":"2017","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.burns.2024.01.026_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14602-7","article-title":"Kr\u00fcpple-like-factor 4 attenuates lung fibrosis via inhibiting epithelial-mesenchymal transition","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.burns.2024.01.026_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12929-019-0566-1","article-title":"Glucosamine impedes transforming growth factor \u03b21-mediated corneal fibroblast differentiation by targeting Kr\u00fcppel-like factor 4","volume":"26","author":"Chen","year":"2019","journal-title":"J Biomed Sci"},{"issue":"4","key":"10.1016\/j.burns.2024.01.026_bib19","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1096\/fj.201902307RRR","article-title":"Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells","volume":"34","author":"Chen","year":"2020","journal-title":"Faseb J"},{"key":"10.1016\/j.burns.2024.01.026_bib20","article-title":"Selective Inhibition of mTORC1 signaling supports the development and maintenance of pluripotency","author":"Kim","year":"2023","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.burns.2024.01.026_bib21","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/nm1671","article-title":"Pim-1 regulates cardiomyocyte survival downstream of Akt","volume":"13","author":"Muraski","year":"2007","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.burns.2024.01.026_bib22","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/jid.2011.150","article-title":"Transcriptional inhibition of hypertrophic scars by a gene silencer, pyrrole-imidazole polyamide, targeting the TGF-\u03b21 promoter","volume":"131","author":"Washio","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.burns.2024.01.026_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/PRS.0b013e3181e6046b","article-title":"Current tools for noninvasive objective assessment of skin scars","volume":"126","author":"Perry","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.burns.2024.01.026_bib24","doi-asserted-by":"crossref","first-page":"E1453","DOI":"10.1152\/ajpendo.00660.2011","article-title":"Role of PRAS40 in Akt and mTOR signaling in health and disease","volume":"302","author":"Wiza","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"27","key":"10.1016\/j.burns.2024.01.026_bib25","doi-asserted-by":"crossref","first-page":"20036","DOI":"10.1074\/jbc.M702376200","article-title":"PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.burns.2024.01.026_bib26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1073\/pnas.95.4.1432","article-title":"RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1","volume":"95","author":"Burnett","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.burns.2024.01.026_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.burns.2024.01.026_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","article-title":"mTORC1 signaling and the metabolic control of cell growth","volume":"45","author":"Ben-Sahra","year":"2017","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"10.1016\/j.burns.2024.01.026_bib29","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1096\/fj.12-219493","article-title":"miR-145 regulates myofibroblast differentiation and lung fibrosis","volume":"27","author":"Yang","year":"2013","journal-title":"Faseb J"},{"issue":"1","key":"10.1016\/j.burns.2024.01.026_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2119\/molmed.2014.00172","article-title":"miR-145 contributes to hypertrophic scarring of the skin by inducing myofibroblast activity","volume":"21","author":"Gras","year":"2015","journal-title":"Mol Med"},{"issue":"2","key":"10.1016\/j.burns.2024.01.026_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.yjmcc.2010.04.008","article-title":"Kr\u00fcppel-like factor 4 regulates pressure-induced cardiac hypertrophy","volume":"49","author":"Liao","year":"2010","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"10.1016\/j.burns.2024.01.026_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063424","article-title":"Kr\u00fcppel-like factor 4 transcriptionally regulates TGF-\u03b21 and contributes to cardiac myofibroblast differentiation","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.burns.2024.01.026_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12967-022-03776-y","article-title":"Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism","volume":"20","author":"Leung","year":"2022","journal-title":"J Transl Med"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417924000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417924000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T19:51:04Z","timestamp":1713988264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417924000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0305417924000275"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2024.01.026","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exogenous PRAS40 reduces KLF4 expression and alleviates hypertrophic scar fibrosis and collagen deposition through inhibiting mTORC1","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2024.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}